Artivion, Inc. (AORT) announced the FDA granted premarket application approval of PERCLOT Absorbable Hemostatic System for use to control bleeding in certain open and laparoscopic surgical procedures.
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and.